Status:
COMPLETED
Elosan Efficacy Study (EES)
Lead Sponsor:
Elosan AG
Conditions:
Chronic Pain
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The "Elosan Cabin" is a closed, electrically insulated, biocompatible cabin for the short-term application of electrostatic high voltage in patients with chronic pain, especially those with rheumatic ...
Detailed Description
Included in the study can be all persons suffering from chronic pain, as it is often the case with rheumatic disease or traumata. The Elosan therapy to be investigated aims to treat chronic pain by ap...
Eligibility Criteria
Inclusion
- Informed Consent
- adults, age ≥ 18 years, male or female patients
- History of pain ≥ 6 months
- Suffering from chronic pain, either reumatic pain or pain caused by traumata
- Intensity of pain rated ≥ 50 mm on VAS pain
Exclusion
- Untreated thyroid disease
- History of seizure disorder (epilepsy)
- History of or current psychosis
- Women who are pregnant, breast feeding or intending to become pregnant
- Patients who are currently participating in other studies or have participated in other studies within the last 30 days
- Patients who have expressed their intention, or are suspected of intending, to discontinue therapy or stop therapy before the end of trial
- Patients with an electric or electronic implant.
Key Trial Info
Start Date :
July 18 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2019
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT03823729
Start Date
July 18 2018
End Date
March 1 2019
Last Update
March 13 2019
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Polymedes Pain Center
Bad Ragaz, CH, Switzerland, 7310
2
Centro Ortho-Bio-Med
Roveredo, CH, Switzerland, 6535
3
Zentrum für Neurochirurgie Hirslanden Ostschweiz
Sankt Gallen, CH, Switzerland, 9016